Related Experiment Videos
2016 New Drug Update.
1Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA.
Summary
This review evaluates six new drugs for elderly patients, including hypnotics, anticoagulants, heart failure treatments, and cholesterol-lowering agents. Each drug is rated using the New Drug Comparison Rating system.
Area of Science:
- Geriatric Pharmacology
- Cardiovascular Therapeutics
- Lipid Management
Background:
- The elderly population frequently experiences conditions requiring pharmacological intervention.
- Recent advancements have introduced new medications targeting common geriatric health issues.
- Objective evaluation of new drugs is crucial for clinical decision-making.
Purpose of the Study:
- To review six recently marketed drugs for conditions prevalent in the elderly.
- To assess the properties, advantages, and disadvantages of these new pharmaceutical agents.
- To provide a comparative rating for each new drug using a standardized system.
Main Methods:
- Selection of six new drugs launched within the past year.
- Analysis of drug uses and key pharmacological properties.
- Application of the New Drug Comparison Rating (NDCR) system for evaluation.
Main Results:
- Detailed discussion of a hypnotic, an anticoagulant, two heart failure drugs, and two lipid-lowering agents.
- Identification of specific benefits and drawbacks for each evaluated medication.
- Assignment of a rating to each drug based on comprehensive assessment.
Conclusions:
- The New Drug Comparison Rating (NDCR) system provides a framework for evaluating new geriatric medications.
- The review highlights the therapeutic landscape of recent drug introductions for elderly care.
- Informed drug selection is facilitated by understanding the comparative performance of new agents.